Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $cybn

Cybin's stock is seeing increased social media attention driven by positive clinical trial results and sector-wide momentum. Investors are discussing potential price targets and the growing institutional interest in psychedelic therapeutics.

### About $cybn
Cybin is a biotechnology company focused on the research and development of psychedelic-based therapeutics.  

### Insights
- $cybn posts created is up XXXXX% from the previous week.

### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$cybn/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$cybn/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXX  
X Week: XXXXX -XXXX%  
X Month: XXXXXXX +28%  
X Months: XXXXXXXXX -XX%  
X Year: XXXXXXXXX +38%  
1-Year High: XXXXXXX on 2025-11-12  
1-Year Low: XX on 2025-12-07  

Engagements by network (24h):
X: XXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$cybn/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$cybn/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX -XX%  
X Months: XXXXX +60%  
X Year: XXXXX +209%  
1-Year High: XXX on 2025-01-07  
1-Year Low: X on 2025-12-07  

Mentions by network (24h):
X: XX

  
  
### Creators: X (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$cybn/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$cybn/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $cybn in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX -XX%  
X Month: XX -XX%  
X Months: XXXXX +199%  
X Year: XXXXX +179%  
1-Year High: XXX on 2025-06-29  
1-Year Low: X on 2025-12-06  

The most influential creators that mention $cybn in the last XX hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@PsychedVantage](/creator/twitter/PsychedVantage) | X    | XXXXX     | X     | XXX         |
| [@theflynews](/creator/twitter/theflynews)         | X    | XXXXXX    | X     | X           |

[View More](/list/creators/$cybn/100)
  
  
### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$cybn/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$cybn/time-series/sentiment.tsv)  
Current Value: XXX%  
Daily Average: XX%  
X Week: XXX% no change  
X Month: XXX% no change  
X Months: XXX% +24%  
X Year: XXX% +3%  
1-Year High: XXX% on 2024-12-22  
1-Year Low: XX% on 2025-05-17  

Most Supportive Themes:
- Positive Clinical Trial Results: (45%) Posts highlight positive outcomes from CYB003 and CYB004 trials, fueling optimism about the company's progress in psychedelic treatments.
- Sector Momentum and Institutional Interest: (30%) Mentions of increased trading volume and institutional interest in psychedelic stocks, including $CYBN, suggest growing confidence in the sector.
- Regulatory Advancements: (15%) News of FDA breakthrough therapy designation and supportive guidance for psychedelic development boosts investor sentiment.
  
Most Critical Themes:
- Market Volatility: (10%) Concerns about overall market conditions and their potential impact on the stock's performance are present.
  

### Top $cybn Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"listen and learn about the biggest psychedelic M&A deal of the year AbbVies $1.2B acquisition of IP of Bretisilocin from psy drug developer Gilgamesh financial disclosure: tweet author participated in the seed round of Gilgamesh during COVID"  
[X Link](https://x.com/psy_dao/status/1998491292268114232) [@psy_dao](/creator/x/psy_dao) 2025-12-09T20:33Z 16.6K followers, 1027 engagements


"Psychedelic Biotech in 2025: What's Next @flobrand and @LarsWilde $ATAI $CMPS $MNMD $CYBN $GHRS"  
[X Link](https://x.com/PsychedVantage/status/1998437829311877601) [@PsychedVantage](/creator/x/PsychedVantage) 2025-12-09T17:01Z 1661 followers, 6069 engagements


"psychedelics are the future in medicine. I am heavily bullish on $ATAI $CYBN $MNMD $PSIL are all really early buys to me to be ahead of this curve. $ATAI 's monthly chart looks overwhelmingly positively bullish now just sit and wait. patience"  
[X Link](https://x.com/Freenu12/status/1998397429465731127) [@Freenu12](/creator/x/Freenu12) 2025-12-09T14:20Z 2401 followers, XXX engagements


"$CYBN - could just keep chopping but like it with a tight stop. First targets at $XXXX and $7.70"  
[X Link](https://x.com/ISAManMoney/status/1998034699718189251) [@ISAManMoney](/creator/x/ISAManMoney) 2025-12-08T14:19Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$cybn

Cybin's stock is seeing increased social media attention driven by positive clinical trial results and sector-wide momentum. Investors are discussing potential price targets and the growing institutional interest in psychedelic therapeutics.

About $cybn

Cybin is a biotechnology company focused on the research and development of psychedelic-based therapeutics.

Insights

  • $cybn posts created is up XXXXX% from the previous week.

Engagements: XXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XXXX%
X Month: XXXXXXX +28%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXX +38%
1-Year High: XXXXXXX on 2025-11-12
1-Year Low: XX on 2025-12-07

Engagements by network (24h): X: XXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX -XX%
X Month: XXX -XX%
X Months: XXXXX +60%
X Year: XXXXX +209%
1-Year High: XXX on 2025-01-07
1-Year Low: X on 2025-12-07

Mentions by network (24h): X: XX

Creators: X (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $cybn in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XX -XX%
X Month: XX -XX%
X Months: XXXXX +199%
X Year: XXXXX +179%
1-Year High: XXX on 2025-06-29
1-Year Low: X on 2025-12-06

The most influential creators that mention $cybn in the last XX hours

Creator Rank Followers Posts Engagements
@PsychedVantage X XXXXX X XXX
@theflynews X XXXXXX X X

View More

Sentiment: XXX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XXX% no change
X Month: XXX% no change
X Months: XXX% +24%
X Year: XXX% +3%
1-Year High: XXX% on 2024-12-22
1-Year Low: XX% on 2025-05-17

Most Supportive Themes:

  • Positive Clinical Trial Results: (45%) Posts highlight positive outcomes from CYB003 and CYB004 trials, fueling optimism about the company's progress in psychedelic treatments.
  • Sector Momentum and Institutional Interest: (30%) Mentions of increased trading volume and institutional interest in psychedelic stocks, including $CYBN, suggest growing confidence in the sector.
  • Regulatory Advancements: (15%) News of FDA breakthrough therapy designation and supportive guidance for psychedelic development boosts investor sentiment.

Most Critical Themes:

  • Market Volatility: (10%) Concerns about overall market conditions and their potential impact on the stock's performance are present.

Top $cybn Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"listen and learn about the biggest psychedelic M&A deal of the year AbbVies $1.2B acquisition of IP of Bretisilocin from psy drug developer Gilgamesh financial disclosure: tweet author participated in the seed round of Gilgamesh during COVID"
X Link @psy_dao 2025-12-09T20:33Z 16.6K followers, 1027 engagements

"Psychedelic Biotech in 2025: What's Next @flobrand and @LarsWilde $ATAI $CMPS $MNMD $CYBN $GHRS"
X Link @PsychedVantage 2025-12-09T17:01Z 1661 followers, 6069 engagements

"psychedelics are the future in medicine. I am heavily bullish on $ATAI $CYBN $MNMD $PSIL are all really early buys to me to be ahead of this curve. $ATAI 's monthly chart looks overwhelmingly positively bullish now just sit and wait. patience"
X Link @Freenu12 2025-12-09T14:20Z 2401 followers, XXX engagements

"$CYBN - could just keep chopping but like it with a tight stop. First targets at $XXXX and $7.70"
X Link @ISAManMoney 2025-12-08T14:19Z XXX followers, XXX engagements

$cybn
/topic/$cybn